跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tidact - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tidact
Approved
STANDARD
Tidact
YSP Industries (M) Sdn. Bhd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
562fe8ec7bbb7c7c
Company
YSP Industries (M) Sdn. Bhd.
Type
Standard
Approval Details
Approval Id
562fe8ec7bbb7c7c
Drug Approval Philippines Name
Tidact
Product Name
Tidact
Registration Number
DR-XY27623
Brand Name
Tidact
Generic Name
Clindamycin (As Hydrochloride)
Dosage Form
Capsule
Dosage Strength
150 mg
Manufacturer
YSP Industries (M) Sdn. Bhd.
Importer
Yung Shin (Philippines), Inc.
Issuance Date
26 May 2022
Expiry Date
21 June 2027
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
562fe8ec7bbb7c7c
Type
Standard
Back to Philippines FDA Approvals